BIVI vs. FBLG
BIVI (BioVie Inc.) and FBLG (FibroBiologics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, BIVI returned -82.72% vs -94.91% for FBLG. At a 0.05 correlation, their price movements are largely independent.
Performance
BIVI vs. FBLG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIVI achieves a 53.45% return, which is significantly higher than FBLG's -83.70% return.
BIVI
- 1D
- -7.29%
- 1M
- 23.61%
- YTD
- 53.45%
- 6M
- 40.16%
- 1Y
- -82.72%
- 3Y*
- -84.51%
- 5Y*
- -74.75%
- 10Y*
- -54.32%
FBLG
- 1D
- -4.70%
- 1M
- -30.83%
- YTD
- -83.70%
- 6M
- -84.46%
- 1Y
- -94.91%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BIVI vs. FBLG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
BIVI BioVie Inc. | 53.45% | -94.20% | -81.13% |
FBLG FibroBiologics, Inc | -83.70% | -88.76% | -93.33% |
Correlation
The correlation between BIVI and FBLG is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2024 | 0.05 |
Fundamentals
BIVI:
$13.43M
FBLG:
$2.77M
BIVI:
-$2.25
FBLG:
-$7.40
BIVI:
0.86
FBLG:
1.06
BIVI:
$0.00
FBLG:
$0.00
BIVI:
-$229.38K
FBLG:
-$465.00K
BIVI:
-$19.89M
FBLG:
-$17.87M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIVI vs. FBLG — Risk / Return Rank
BIVI
FBLG
BIVI vs. FBLG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioVie Inc. (BIVI) and FibroBiologics, Inc (FBLG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIVI | FBLG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | +0.65 | ||
| Omega ratioGain probability vs. loss probability | 0.79 | 0.71 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | -1.00 | +0.08 |
| Martin ratioReturn relative to average drawdown | -1.03 | -1.58 | +0.55 |
Loading charts...
Drawdowns
BIVI vs. FBLG - Drawdown Comparison
The maximum BIVI drawdown since its inception was -99.98%, roughly equal to the maximum FBLG drawdown of -99.88%. Use the drawdown chart below to compare losses from any high point for BIVI and FBLG.
Loading charts...
Drawdown Indicators
| BIVI | FBLG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -99.88% | -0.10% |
Max Drawdown (1Y)Largest decline over 1 year | -89.71% | -94.89% | +5.18% |
Max Drawdown (3Y)Largest decline over 3 years | -99.80% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -99.94% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | — | — |
Current DrawdownCurrent decline from peak | -99.97% | -99.88% | -0.09% |
Average DrawdownAverage peak-to-trough decline | -79.69% | -90.57% | +10.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 80.56% | 60.15% | +20.41% |
Volatility
BIVI vs. FBLG - Volatility Comparison
BioVie Inc. (BIVI) has a higher volatility of 23.15% compared to FibroBiologics, Inc (FBLG) at 19.59%. This indicates that BIVI's price experiences larger fluctuations and is considered to be riskier than FBLG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIVI | FBLG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.15% | 19.59% | +3.56% |
Volatility (6M)Calculated over the trailing 6-month period | 55.12% | 107.34% | -52.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 96.69% | 122.05% | -25.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 128.88% | 150.96% | -22.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 186.80% | 150.96% | +35.84% |
Dividends
BIVI vs. FBLG - Dividend Comparison
Neither BIVI nor FBLG has paid dividends to shareholders.
Financials
BIVI vs. FBLG - Financials Comparison
This section allows you to compare key financial metrics between BioVie Inc. and FibroBiologics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BIVI and FBLG have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIVI has higher volatility (23.15%) compared to FBLG (19.59%). In terms of maximum drawdown, BIVI dropped -99.98% vs FBLG's -99.88%.
FBLG currently has the higher Sharpe Ratio (-0.78 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIVI and FBLG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer